Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells. Aguirre-Alvarado, C., Segura-Cabrera, A., Velazquez-Quesada, I., Hernandez-Esquivel, M. A., Garcia-Perez, C. A., Guerrero-Rodriguez, S. L., Ruiz-Moreno, A. J., Rodriguez-Moreno, A., Perez-Tapia, S. M., & Velasco-Velazquez, M. A. Oncotarget, 7(17):23772–23784, Apr, 2016.
bibtex   
@Article{pmid27009862,
   Author="Aguirre-Alvarado, C.  and Segura-Cabrera, A.  and Velazquez-Quesada, I.  and Hernandez-Esquivel, M. A.  and Garcia-Perez, C. A.  and Guerrero-Rodriguez, S. L.  and Ruiz-Moreno, A. J.  and Rodriguez-Moreno, A.  and Perez-Tapia, S. M.  and Velasco-Velazquez, M. A. ",
   Title="{{V}irtual screening-driven repositioning of etoposide as {C}{D}44 antagonist in breast cancer cells}",
   Journal="Oncotarget",
   Year="2016",
   Volume="7",
   Number="17",
   Pages="23772--23784",
   Month="Apr"
}

% 27006402

Downloads: 0